Our Focus: Pipeline

Graphite Bio brings an ambitious vision to advance gene editing from the bench to the bedside – transforming our founders’ ground-breaking discoveries into therapies that make a meaningful difference in patients’ lives. The Company is uniting advancements in hematopoietic stem cell (HSC) transplantation and gene editing to ultimately create next-generation therapies with broad potential.

GRAPHITE BIO gene editing pipeline 2021JAN10